This gap narrows slightly at higher doses (15 mg compounded costs $60-120 per week, compared to $1,069 for brand-name 15 mg pens), but compounded remains substantially cheaper across the entire dose range
7 Discussion GLP-1 RAs have shown effects beyond their initial application in managing T2DM
4.3 Dual GIP/GLP-1 receptor agonists The unimolecular dual incretin receptor agonist offers a more physiological approach to managing diseases associated with T2DM compared to GLP-1RAs alone
While the majority of patients on GLP-1s take them at the standard doses, more and more people are starting to talk about microdosing instead
These are starting ranges only
Theoretically, yes some individuals may be able to inject GLP-1 medications less frequently (like every 10 or even 14 days), especially those with slower metabolism, strong response at low doses, or fewer metabolic demands